These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35495636)

  • 1. Lipid Alterations in Early-Stage High-Grade Serous Ovarian Cancer.
    Iurova MV; Chagovets VV; Pavlovich SV; Starodubtseva NL; Khabas GN; Chingin KS; Tokareva AO; Sukhikh GT; Frankevich VE
    Front Mol Biosci; 2022; 9():770983. PubMed ID: 35495636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
    Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
    J Proteome Res; 2023 Jun; 22(6):2092-2108. PubMed ID: 37220064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
    Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.
    Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
    Front Chem; 2023; 11():1332816. PubMed ID: 38260043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrahigh Resolution Lipid Mass Spectrometry Imaging of High-Grade Serous Ovarian Cancer Mouse Models.
    Ma X; Botros A; Yun SR; Park EY; Kim O; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
    Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
    Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
    Berkel C; Cacan E
    Hum Cell; 2021 May; 34(3):862-877. PubMed ID: 33576947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Free Amino Acid Profiling in Differential Diagnosis of Ovarian Tumors-A Comparative Study with Review of the Literature.
    Horala A; Plewa S; Derezinski P; Klupczynska A; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33672144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Metabolomics of a High-Grade Serous Ovarian Cancer Triple-Knockout Mouse Model.
    Huang D; Gaul DA; Nan H; Kim J; Fernández FM
    J Proteome Res; 2019 Aug; 18(8):3184-3194. PubMed ID: 31290664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications.
    Chen L; Tang Q; Zhang K; Huang Q; Ding Y; Jin B; Liu S; Hwa K; Chou CJ; Zhang Y; Thyparambil S; Liao W; Han Z; Mortensen R; Schilling J; Li Z; Heaton R; Tian L; Cohen HJ; Sylvester KG; Arent RC; Zhao X; McElhinney DB; Wu Y; Bai W; Ling XB
    BMC Cancer; 2023 Sep; 23(1):844. PubMed ID: 37684587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer.
    Lokman NA; Ricciardelli C; Stephens AN; Jobling TW; Hoffmann P; Oehler MK
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33406648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in lipid profile upon uterine fibroids and its recurrence.
    Tonoyan NM; Chagovets VV; Starodubtseva NL; Tokareva AO; Chingin K; Kozachenko IF; Adamyan LV; Frankevich VE
    Sci Rep; 2021 Jun; 11(1):11447. PubMed ID: 34075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in tumor markers, coagulation function and serum VEGF in patients with ovarian cancer and benign ovarian disease.
    Wang J; Zhu M; Zhou X; Wang T; Zhang J
    J BUON; 2020; 25(5):2287-2292. PubMed ID: 33277847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
    Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
    Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
    Wang J; Wu H; Zhang Y; Zhang Y; Li X; Zhao Q; Meng F; Huang Q; Wang Y
    Int J Clin Exp Pathol; 2017; 10(8):8222-8232. PubMed ID: 31966673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass.
    Buas MF; Drescher CW; Urban N; Li CI; Bettcher L; Hait NC; Moysich KB; Odunsi K; Raftery D; Yan L
    Sci Rep; 2021 Sep; 11(1):18156. PubMed ID: 34518593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer.
    Liljedahl L; Malmström J; Kristjansdottir B; Waldemarson S; Sundfeldt K
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.